CORZQ — Core Scientific Income Statement
0.000.00%
Last trade - 00:00FinancialsHighly SpeculativeSmall CapNeutral
- $110.76m
- $1.13bn
- $544.48m
Annual income statement for Core Scientific, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS |
| Standards: | USG | USG | USG |
| Status: | Final | Final | Final |
| Revenue | |||
| Total Revenue | 59.5 | 60.3 | 544 |
| Cost of Revenue | |||
| Gross Profit | 10.5 | 9.39 | 239 |
| Selling / General / Administrative Expenses | |||
| Research And Development | |||
| Depreciation and Amortization | |||
| Unusual Expense / Income | |||
| Total Operating Expenses | 71.2 | 68 | 421 |
| Operating Profit | -11.7 | -7.66 | 123 |
| Total Net Non Operating Interest Income / Expense | |||
| Other Net Non Operating Costs | |||
| Net Income Before Taxes | -11.9 | -12.2 | 63.1 |
| Provision for Income Taxes | |||
| Net Income After Taxes | -11.9 | -12.2 | 47.3 |
| Net Income Before Extraordinary Items | |||
| Net Income | -11.9 | -12.2 | 47.3 |
| Adjustments to Net Income | |||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||
| Income Available to Common Shareholders Including Extraordinary Items | |||
| Diluted Net Income | -11.9 | -22.7 | 47.3 |
| Diluted Weighted Average Shares | |||
| Basic EPS Including Extraordinary Items | |||
| Diluted EPS Including Extraordinary Items | |||
| Diluted EPS Excluding Extraordinary Items | |||
| Normalised Income Before Taxes | |||
| Normalised Income After Taxes | |||
| Normalised Income Available to Common Shareholders | |||
| Diluted Normalised EPS | -0.04 | -0.086 | 0.251 |
| Dividends per Share |